# reload+after+2024-01-20 11:43:44.282698
address1§3940 Trust Way
city§Hayward
state§CA
zip§94545
country§United States
phone§510 780 0819
website§https://benitec.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.
fullTimeEmployees§17
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Jerel A. Banks M.D., Ph.D.', 'age': 48, 'title': 'Executive Chairman & CEO', 'yearBorn': 1975, 'fiscalYear': 2023, 'totalPay': 848068, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Megan Joan Boston BComm, CA, Dip., GAICD', 'age': 51, 'title': 'Executive Director', 'yearBorn': 1972, 'fiscalYear': 2023, 'totalPay': 439168, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Michael  Graham', 'title': 'Head of Discovery & Founding Scientist', 'fiscalYear': 2023, 'totalPay': 130022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Claudia  Kloth', 'title': 'Senior Vice President of Manufacturing', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.848
priceToSalesTrailing12Months§112.15794
currency§USD
dateShortInterest§1702598400
forwardEps§-2.41
exchange§NCM
quoteType§EQUITY
shortName§Benitec Biopharma Inc.
longName§Benitec Biopharma Inc.
firstTradeDateEpochUtc§1403616600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b3cc27a2-16b5-3a55-8f58-57577c96b7a7
gmtOffSetMilliseconds§-18000000
targetHighPrice§6.0
targetLowPrice§6.0
targetMeanPrice§6.0
targetMedianPrice§6.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§5.716
grossMargins§2.4133298
ebitdaMargins§0.0
trailingPegRatio§None
